[HTML][HTML] Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis
Y Liu, Y Zhang, G Feng, Q Niu… - Experimental and …, 2017 - spandidos-publications.com
… , no clinical trials comparing the success rate of gefitinib, erlotinib and icotinib … compare the
effectiveness and adverse effects of gefitinib, erlotinib and icotinib for the treatment of patients …
effectiveness and adverse effects of gefitinib, erlotinib and icotinib for the treatment of patients …
[HTML][HTML] A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George… - Indian Journal of …, 2019 - journals.lww.com
… Adverse drug reaction of both erlotinib (n=37) and gefitinib (n=34) … Terminology Criteria for
Adverse Events grading system. … erlotinib and gefitinib had similar effectiveness but gefitinib …
Adverse Events grading system. … erlotinib and gefitinib had similar effectiveness but gefitinib …
[HTML][HTML] Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2019 - ncbi.nlm.nih.gov
… with more efficient management of adverse events may in part … 3 or 4 adverse events for
afatinib, gefitinib, and erlotinib were … gefitinib and erlotinib have both demonstrated efficacy for …
afatinib, gefitinib, and erlotinib were … gefitinib and erlotinib have both demonstrated efficacy for …
[HTML][HTML] Risk of treatment-related toxicities from EGFR tyrosine kinase inhibitors: a meta-analysis of clinical trials of gefitinib, erlotinib, and afatinib in advanced EGFR …
… be based on assessing differences in effectiveness of each … In a direct head-to-head
comparison of second- versus first-… over gefitinib but higher drug-related severe adverse events …
comparison of second- versus first-… over gefitinib but higher drug-related severe adverse events …
[HTML][HTML] Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non‑small cell lung cancer in patients with common and rare EGFR gene …
P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… of the EGFR-TKIs observed in our study, the type and severity of adverse events was
similar to those described in previous clinical trials (12). For example, afatinib and …
similar to those described in previous clinical trials (12). For example, afatinib and …
Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: a meta‐analysis
… greater efficacy than gefitinib or erlotinib in … differences have led to the assumption that
erlotinib is more effective and at the same time associated with more adverse events than gefitinib…
erlotinib is more effective and at the same time associated with more adverse events than gefitinib…
[HTML][HTML] Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis
W Zhang, Y Wei, D Yu, J Xu, J Peng - Medicine, 2018 - journals.lww.com
… for the selection of targeted drugs, we conducted a meta-analysis of studies to compare
the antitumor effectiveness and adverse effects (AEs) of gefitinib and erlotinib for NSCLC. …
the antitumor effectiveness and adverse effects (AEs) of gefitinib and erlotinib for NSCLC. …
[HTML][HTML] A retrospective comparison of the clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients with non-small cell lung cancer
A Fujiwara, M Yoshida, H Fujimoto, H Nakahara… - Oncology …, 2018 - ncbi.nlm.nih.gov
… compare the effectiveness of gefitinib, erlotinib, and afatinib. We retrospectively reviewed the
records of 310 patients … frequent and milder grade of adverse effects. However, comparable …
records of 310 patients … frequent and milder grade of adverse effects. However, comparable …
[HTML][HTML] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
JJ Yang, Q Zhou, HH Yan, XC Zhang, HJ Chen… - British journal of …, 2017 - nature.com
… to determine whether erlotinib is superior to gefitinib in efficacy. … the incidence and severity
of adverse events (AEs), according … differences in efficacy or toxicity profile between first-line …
of adverse events (AEs), according … differences in efficacy or toxicity profile between first-line …
[HTML][HTML] Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: a meta …
W Zhang, Y Wei, D Yu, J Xu, J Peng - BMC cancer, 2018 - Springer
… To resolve this controversy, we conducted a meta-analysis of related studies to compare the
anti-tumor efficacy and adverse effects (AEs) of gefitinib and erlotinib for treating East Asian …
anti-tumor efficacy and adverse effects (AEs) of gefitinib and erlotinib for treating East Asian …